Evidence map›Paper›PMID 28282855›Full record

ArticleInternational journal of molecular sciences2017

Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations.

Bodil Ohlsson, Marju Orho-Melander, Peter M Nilsson

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis.Liver international : official journal of the International Association for the Study of the Liver · 2020
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Observational
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bodil OhlssonDepartment of Internal Medicine, Skane University Hospital, Lund University, 205 02 Malmö, Sweden. bodil.ohlsson@med.lu.se.
Marju Orho-MelanderGenetic Epidemiology, Diabetes and Cardiovascular Disease, Lund University, 205 02 Malmö, Sweden. marju.orho-melander@med.lu.se.
Peter M NilssonDepartment of Internal Medicine, Skane University Hospital, Lund University, 205 02 Malmö, Sweden. peter.nilsson@med.lu.se.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zonulin is considered a biomarker of increased intestinal permeability, and elevated levels have been found in celiac disease. The primary aim of this study was to examine the association between serum zonulin levels and gastrointestinal (GI) symptoms, and secondarily, between zonulin levels and anthropometric and metabolic factors. The offspring (

Indexed as

PhenotypeAdultBiomarkersBlood GlucoseBlood PressureBody Weights and MeasuresCholera ToxinFemaleGastrointestinal DiseasesHaptoglobinsHumansHyperlipidemiasMaleMiddle AgedObesityPopulation SurveillanceBiomarkersBlood GlucoseCholera ToxinHaptoglobinsProtein Precursorszonulinblood pressuregastrointestinal disordersgastrointestinal symptomshyperlipidemiaobesityoverweightzonulin

Identifiers

PMID28282855
PMCPMC5372598
OpenAlexW2592430395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.